发明名称 High affinity antibody antagonists of interleukin-13 receptor alpha 1
摘要 High affinity antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are effective in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13Rα1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing IL-13Rα1-mediated activities are also disclosed.
申请公布号 US9371388(B2) 申请公布日期 2016.06.21
申请号 US201314052791 申请日期 2013.10.14
申请人 CSL Limited 发明人 Nash Andrew Donald;Baca Manuel;Fabri Louis Jerry;Zaller Dennis;Strohl William R.;An Zhiqiang
分类号 A61K39/395;C07K16/28 主分类号 A61K39/395
代理机构 Licata & Tyrrell P.C. 代理人 Licata & Tyrrell P.C.
主权项 1. An isolated antibody that binds to human interleukin 13 receptor alpha 1, comprising: (a) a heavy chain variable region comprising CDR1, CDR2, and CDR3 amino acid sequences as set forth in SEQ ID NO:82, SEQ ID NO:83, and SEQ ID NO:7, respectively; and (b) a light chain variable region comprising CDR1, CDR2, and CDR3 amino acid sequences as set forth in SEQ ID NO:84, SEQ ID NO:85, and SEQ ID NO:38, respectively.
地址 Parkville, Victoria AU